Related references
Note: Only part of the references are listed.Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival
Huijie Zhou et al.
ANNALS OF HEMATOLOGY (2023)
End of treatment FDG-PET in primary mediastinal B-cell lymphoma treated with R-chemotherapy: Prognostic indicator and implications for consolidation radiotherapy
Ana Carolina Freitas et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2022)
Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics
Zahoor Ahmed et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Current and emerging treatment options in primary mediastinal B-cell lymphoma
Bita Fakhri et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2021)
Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
Tove Wasterlid et al.
BLOOD CANCER JOURNAL (2021)
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up
Hui Zhou et al.
BLOOD CANCER JOURNAL (2020)
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach
Anna R. Hayden et al.
BLOOD (2020)
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma
Esther Hian Li Chan et al.
CANCER MEDICINE (2019)
Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study
Luca Ceriani et al.
HEMATOLOGICAL ONCOLOGY (2017)
Primary mediastinal large B-cell lymphoma
Maurizio Martelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis
Matthew W. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Racial patterns of patients with primary mediastinal large B-cell lymphoma SEER analysis
Pan-Pan Liu et al.
MEDICINE (2016)
Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis
Smith Giri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients
Pier Luigi Zinzani et al.
HEMATOLOGICAL ONCOLOGY (2015)
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma
Abraham Avigdor et al.
ANNALS OF HEMATOLOGY (2014)
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
Kieron Dunleavy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The molecular pathogenesis of primary mediastinal large B-cell lymphoma
Christian Steidl et al.
BLOOD (2011)
Primary mediastinal large B-cell lymphoma
Maurizio Martelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience
KJ Savage et al.
ANNALS OF ONCOLOGY (2006)
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated-with CHOP or MACOP-B/VACOP-B
G Todeschini et al.
BRITISH JOURNAL OF CANCER (2004)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
Share Paper
